Heterologous prime–boost vaccinations for poverty-related diseases: advantages and future prospects
Expert Review of Vaccines, 2009 Classical vaccination approaches, based on a single vaccine administered in a homologous prime-boost schedule and optimized to induce primarily neutralizing antibodies, are unlikely to be sufficiently efficacious to prevent TB, malaria or HIV infections. Novel vaccines, capable of inducing a more powerful immune response, in particular T-cell immunity,
Ariane Rodríguez, Katarina Radosevic
exaly +3 more sources
Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2. [PDF]
Lancet Infect Dis, 2021 Tenbusch M +19 more
europepmc +5 more sources
Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials
Viruses, 2010 Currently, there are more than 30 million people infected with HIV-1 and thousands more are infected each day. Vaccination is the single most effective mechanism for prevention of viral disease, and after more than 25 years of research, one vaccine has shown somewhat encouraging results in an advanced clinical efficacy trial. A modified intent-to-treat
Pamela Freiden +2 more
exaly +4 more sources
Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression [PDF]
Cell Reports, 2023 Robert Seder
exaly +2 more sources
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data [PDF]
Lancet, The, 2021 Matthew Snape
exaly +5 more sources
Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia? [PDF]
Front Public Health, 2022 Gelanew T +6 more
europepmc +4 more sources
Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination [PDF]
Vaccines, 2023 Sang Moo Kang +2 more
exaly +2 more sources
Heterologous prime-boost vaccination with VLA2001 and an ORFV-based vector enhances spike- and nucleocapsid-specific immunity in mice [PDF]
Frontiers in ImmunologyMelanie Müller +2 more
exaly +2 more sources
Heterologous prime-boost immunization with CoronaVac and Convidecia [PDF]
, 2021 ABSTRACT Background The safety and immunogenicity of heterologous prime-boost COVID-19 vaccine regimens with one shot of a recombinant adenovirus type-5-vectored COVID-19 vaccine Convidecia has not been reported.
Jingxin Li +20 more
openaire +1 more source
To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination [PDF]
Expert Review of Vaccines, 2021 Daniel Tsung-Ning Huang +2 more
exaly +2 more sources